PPP3CA and colorectal cancer: Interestingly, NFATC4 knockdown can reverse the chemoresistance of CAMTA1-silenced colorectal cancer cells to oxaliplatin, and this cellular event is partly mediated by an interacting protein, PPP3CA, which together with CAMTA1, competitively binds to NFATc4.